Niagen Bioscience, Inc. Market Cap ($187.96 Million)
Market Cap & Net Worth: Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. market cap. Niagen Bioscience, Inc. (NASDAQ:NAGE) has a market capitalization of $187.96 Million ($187.96 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16557 globally and #3951 in its home market, demonstrating a -3.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Niagen Bioscience, Inc.'s stock price $2.36 by its total outstanding shares 79644327 (79.64 Million). Also see NAGE cash flow metrics for how efficiently the company converts equity into cash flow.
Niagen Bioscience, Inc. Market Cap History (2025–2026)
Niagen Bioscience, Inc. market cap history from 2025 to 2026. Data shows change from $506.54 Million to $187.96 Million (-51.47% CAGR). Check Niagen Bioscience, Inc. stock quote for real-time trading data and today's change.
Index Memberships
Niagen Bioscience, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.01% | #448 of 976 |
Weight: Niagen Bioscience, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Niagen Bioscience, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Niagen Bioscience, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Niagen Bioscience, Inc. to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.91x
Niagen Bioscience, Inc.'s market cap is 3.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.14x
Niagen Bioscience, Inc.'s market cap is 29.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $506.54 Million | $129.42 Million | $17.38 Million | 3.91x | 29.14x |
Competitor Companies of NAGE by Market Capitalization
Companies near Niagen Bioscience, Inc. in the global market cap rankings as of November 4, 2026. Also see NAGE total asset value for a full breakdown of the balance sheet.
Key companies related to Niagen Bioscience, Inc. by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #542 globally with a market cap of $49.71 Billion USD ( €42.52 Billion EUR).
- Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €92.00 |
| #102 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.41 |
| #542 | Danone SA | PA:BN | $49.71 Billion | €66.02 |
| #674 | Danone SA | F:BSND | $39.61 Billion | €13.00 |
Market Capitalization of Niagen Bioscience, Inc. (2025–2026)
Market capitalization of Niagen Bioscience, Inc. from 2025 to today. Between 2025 and today, Niagen Bioscience, Inc.'s market cap moved from $506.54 Million to $ 187.96 Million, with a yearly change of -51.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $187.96 Million | -62.89% |
| 2025 | $506.54 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Niagen Bioscience, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $187.96 Million USD |
| MoneyControl | $187.96 Million USD |
| MarketWatch | $187.96 Million USD |
| marketcap.company | $187.96 Million USD |
| Reuters | $187.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Niagen Bioscience, Inc.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulat… Read more